In this work, we describe the identification of desvenlafaxine in extended release capsules of venlafaxine (VEN) in acid degradation studies. We developed a stability indicating reverse-phase HPLC method and validated for the analysis of VEN in pharmaceutical formulation. The HPLC method was linear over the range of 0.45-1.05 mg/ml (r 2 =0.999). The RSD values for intra-and inter-day precision studies showed good results (RSD < 2%) and accuracy was greater than 99%. The degradation studies in acidic media for 24 h showed two additional peaks, which were further identified by ESI-MS/MS as the desvenlafaxine and the dehydration product of venlafaxine.
Introduction
Venlafaxine (VEN), chemically known as 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl] cyclohexanol hydrochloride ( Fig.   1 ), a third generation antidepressant (MUTH et al., 1986; TZANAKAKI et al., 2000) , inhibits the reuptake of serotonin, norepinephrine and to a lesser extent dopamine, is a serotonin noradrenalin reuptake inhibitor (MUTH et al., 1985; SCHWEITZER et al., 1991; ANDREWS et al., 1996) . In human, VEN is well absorbed and extensively metabolized to desvenlafaxine (Odesmethylvenlafaxine), the major active metabolite of venlafaxine, and two less active metabolites N-desmethyl and N, O-didesmethyl (HICKS et al., 1994) (Fig. 1) .
Figure 1. Structures of venlafaxine (1), its active metabolite desvenlafaxine (2), and its other metabolites N,O-didesmethyl (3) and N-desmethyl (4).
Since the clinical use of VEN has become increasingly common, various methods are reported in literature for its analyses in human plasma or serum including GC (WILLE et al., 2007) , HPLC (VU et al., 1997; TITIER et al., 2003; WASCHGLER et al., 2004) , LC-MS (BHATT et al., 2005; LIU, CAI and LI, 2007) and CE (RUDAZ et al., 2000) . However, all of these methods are applied to biological fluids and utilized for VEN drug monitoring metabolism and pharmacokinetics studies. For determining VEN in pharmaceutical formulations, just three stability-indicating methods using HPLC have been described (MAKHIJA and VAVIA, 2002; RAO and RAJU, 2006; BERNARDI et al., 2009 ).
Additionally, the in vitro determination of gastric and intestinal stability of VEN was studied (ASAFU-ADJAYE et al., 2007) . However, only one of these previous studies elucidated the structure of one degradation product generated in acidic media by applying LC-MS (ASAFU-ADJAYE et al., 2007) . 
Preparation of Standard and Sample Stock Solutions
The reference stock solution of VEN was prepared by accurately weighing (37.5 mg) and dissolving in a 50 ml volumetric flask with methanol to obtain a concentration of 0.75 mg/ml of analyte.
To prepare the sample stock solution, 
Method Validation
The method was validated following the parameters such as specificity, linearity, precision, accuracy, limits of detection and quantitation and robustness, following the ICH guidelines (ICH, 2005) . Furthermore, stabilityindicating capability was determined by forced degradation conditions also in accordance with , 2005) .
Specificity
The specificity of the method was evaluated with regards to interference due to the presence of excipients in the pharmaceutical formulation.
The placebo samples consisted of all the excipients without the active substance. Then, the specificity of the method was established by determining the peak purity of VEN in samples using a PDA detector, ranging between 190-400 nm.
Linearity and Limits of Detection and Quantitation
The calibration curves were prepared in mobile phase and analyzed at five different VEN reference substance concentrations corresponding to 60%, 80%, 100%, 120% and 140% of the nominal analytical concentration.
The procedure was carried out in duplicate for each concentration. The analyte peak area ratios obtained (dimensionless numbers) were plotted against the corresponding concentrations of the analytes (expressed as mg/ml) and the calibration curves were set up by means of the least-square method. In order to estimate the limit of detection (LOD) and limit of quantification (LOQ), mobile phase was injected twenty times. The LOD was calculated to be three times the noise value and ten times the noise gave LOQ, according to USP guidelines (USP, 2007) .
Precision
The precision was determined using the parameters of repeatability (intra-day) and intermediate precision ( 
Robustness
In this study, the chromatographic parameters (retention time, theoretical plates, tailing factor, retention factor and repeatability)
were evaluated using both sample and reference substance solutions (0.75 mg/ml) changing flow rate (0.9, 1.0 and 1.1 ml/min), buffer concentration (74, 75 and 76%) and pH (6.7, 6.8 and 6.9) of mobile phase, and columns (XTerra C8 column, two different lots).
The stability of reference and sample solutions was also evaluated at the moment they were prepared and after 2, 4, 6, 8, 10, 12 and 15 h. The stability of these solutions was Following the degradation period, all samples were prepared for analysis as previously described. For peak purity test, a PDA detector was used in scan mode (190 -400 nm) and the purity factor was observed.
MS Analysis
The degradation products were evaluated by HPLC, samples peaks were collected from a semi-preparative HPLC using the mobile phase described before. 
Results and Discussion

Selection of Chromatographic Conditions
The chromatographic conditions were optimized to develop a stability-indicating method to separate the degradation products from the drug. To obtain the best chromatographic conditions, the wavelength for detection, the column, and the mobile phase composition were adequately selected. The best chromatographic condition was achieved using disodium hydrogen phosphate buffer 40 mM containing triethylamine (pH 6.8) and acetonitrile (75:25, v/v).
The flow rate used was 1.0 ml/min. PDA detection was used to select the best wavelength for analysis as well as to verify peak purity during analysis. With this mobile phase, adequate results were obtained in terms of peak parameters (shape peak, selectivity, theoretical plates, symmetry, capacity factor, repeatability). A typical chromatogram obtained by the proposed method for VEN is shown in Figure 2A .
System suitability
The system suitability assessment for this HPLC method established instrument performance parameters such as the retention factor, k, theoretical plates number, N, and tailing factor, T f , for VEN. The mean (n = 6) k,
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Tf and N were 2.76, 1.6 and 3201.4 plates/m, respectively, for VEN reference substance.
Linearity and Limits of Detection (LOD) and Quantitation (LOQ)
The calibration 
Precision and Accuracy
The intermediate precision was assessed by analyzing one sample of the pharmaceutical formulation on two different days by the same analyst, showed good results: 99.81 and 101.07% (Table 1 ). The maximum RSD value for inter-day precision was 0.55% (n = 6).
Between-analysts precision was determined by calculating the RSD for the analysis of one samples of the pharmaceutical formulation by Carneiro, W. J. et al./Revista Eletrônica de Farmácia Vol 7 (1), 39-53, 2010. two analysts; the maximum value was found to be 0.67% (Table 1 ).
In the accuracy test three concentrations were evaluated (0.60, 0.75 and 0.90 mg/ml) and mean recoveries were 99.73, 100.11, and 100.25% with a mean value of 100.03% and RSD of 0.27% (Table 2) . These results show that the method was accurate within the desired range. 
Robustness
The results and experimental range of the selected variables evaluated in the robustness assessment are shown in Table 3 . Variations of flow rate (0.9, 1.0 and 1.1 ml/min), mobile phase pH (6.7, 6.8 and 6.9), oven temperature (retention time 4.32 min) (Makhija and Vavia, 2002; Asafu-Adjaye et al., 2007) . However, the forced degradation studies in acidic media at 60 º C for 24 h produced two additional eluting peaks: one with a shorter retention time than the VEN peak and other late eluting peak (RT 3.12 min and RT 9.34, respectively) (Fig. 2B ).
This is contrary to findings by Asafu-Adjaye and co-workers (17) who reported that acid degradation studies at 70 º C for 1 h of VEN did produce just the late eluting peak and also to findings reported by Makhija and Vavia (Makhija and Vavia, 2002) who described just the presence of the shorter additional eluting peak, using different acid and chromatographic conditions. Furthermore, the acid degraded sample 60 º C for 50 h showed just one additional peak, the late eluting peak (Fig. 2C ).
The two additional eluting peaks detected by the LC-UV method were further identified by ESI-MS/MS, in order provide structural characterization of the degradants. The m/z values of the drug and degradation products at full-scam mode were observed at 278.1, 264.2 and 260.1 (Fig. 3 ), corresponding to peaks 1, 2 and 3 (Fig. 2) Combining the information obtained from chromatographic profiles (Fig. 2 ) with MS data (Fig. 3) , product-ion (Fig. 4) and the precursorion (Fig. 5 ) experiments, the molecular structures were rationalized for two degradation products. Moreover, Figure 5 shows that the degradation products followed a very similar fragmentation pattern to the drug. in common structure proposed here, whereas the precursor-ion for this common fragment came from VEN and its degradant products, as depicted in Figure 5 .
Conclusions
In conclusion, the acid degradation studies of VEN showed two degradation products, which were characterized by ESI-MS/MS as the desvenlafaxine and the dehydration product of venlafaxine. 
